Recent Finacing
Recent Raise
Surface Ophthalmics develops ophthalmic therapeutics for ocular surface diseases, advancing three candidates—including topical SURF-100 and SURF-200—using the Klarity delivery vehicle and a 505(b)(2) pathway.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Surface Ophthalmics.
